Synthetic lethality exploits tumor weakness when two mutant genes are combines. Targeting FEN1 gene killed breast and ovarian cancer cell lines with BRCA1 and BRCA2 mutations.
from Medindia Health News https://ift.tt/3hMoLw1
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
July 28, 2020
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.